Abstract:Alzheimer's disease (AD), Parkinson's disease (PD), Frontotemporal Dementia (FTD), and Amyotrophic lateral sclerosis (ALS) are complex and fatal neurodegenerative diseases. While current treatments for these diseases do alleviate some symptoms, there is an imperative need for novel treatments able to stop their progression. For all of these ailments, most cases occur sporadically and have no known genetic cause. Only a small percentage of patients bear known mutations which occur in a multitude of genes. Hence, it is clear that genetic factors alone do not explain disease occurrence. Chromatin, a DNA-histone complex whose basic unit is the nucleosome, is divided into euchromatin, an open form accessible to the transcriptional machinery, and heterochromatin, which is closed and transcriptionally inactive. Protruding out of the nucleosome, histone tails undergo post-translational modifications (PTMs) including methylation, acetylation, and phosphorylation which occur at specific residues and are connected to different chromatin structural states and regulate access to transcriptional machinery. Epigenetic mechanisms, including histone PTMs and changes in chromatin structure, could help explain neurodegenerative disease processes and illuminate novel treatment targets. Recent research has revealed that changes in histone PTMs and heterochromatin loss or gain are connected to neurodegeneration. Here, we review evidence for epigenetic changes occurring in AD, PD, and FTD/ALS. We focus specifically on alterations in the histone PTMs landscape, changes in the expression of histone modifying enzymes and chromatin remodelers as well as the consequences of these changes in heterochromatin structure. We also highlight the potential for epigenetic therapies in neurodegenerative disease treatment. Given their reversibility and pharmacological accessibility, epigenetic mechanisms provide a promising avenue for novel treatments. Altogether, these findings underscore the need for thorough characterization of epigenetic mechanisms and chromatin structure in neurodegeneration.

DNA Damage and Chromatin Rearrangement Work Together to Promote Neurodegeneration

Mechanisms of DNA damage‐mediated neurotoxicity in neurodegenerative disease

Proteins Associated with Neurodegenerative Diseases: Link to DNA Repair

DNAJ Proteins in neurodegeneration: essential and protective factors

DNA Damage Response and Cytoskeletal Protein Crosstalk on Neurodegeneration

Histone post-translational modification and heterochromatin alterations in neurodegeneration: revealing novel disease pathways and potential therapeutics

Introducing the Role of Genotoxicity in Neurodegenerative Diseases and Neuropsychiatric Disorders

Progresses on study of epigenetics in neurodegenerative disorders

Polyglutamine Expansion in Huntingtin and Mechanism of DNA Damage Repair Defects in Huntington's Disease

DNA Damage Repair in Huntington’s Disease and Other Neurodegenerative Diseases

Protein aggregation and its affecting mechanisms in neurodegenerative diseases

DNA damage response in neurodevelopment and neuromaintenance.

A review of proposed mechanisms for neurodegenerative disease

DNA Damage Accumulation in Aging Brain and Its Links to Alzheimer’s Disease Progression

All Roads Lead to Rome: Different Molecular Players Converge to Common Toxic Pathways in Neurodegeneration

DNA Damage-Mediated Neurotoxicity in Parkinson’s Disease

Broken Strands, Broken Minds: Exploring the Nexus of DNA Damage and Neurodegeneration

DNA Damage Response in Neurodevelopment and Neuromaintenance

Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases

DNA Methylation, a Hand Behind Neurodegenerative Diseases

Poly (ADP-ribose) polymerase 1 and neurodegenerative diseases: past, present, and future